Kandu Health merges with BCI company Neurolutions

The merger brings together Neurolutions’ brain computer interface technology and Kandu Health’s telehealth services to try and improve stroke care.

By Nick Paul Taylor • April 9, 2025

Eargo, Hearx merge into one OTC hearing aid firm, receive $100M boost

Hearx, the maker of Lexie hearing aids, and Eargo competed for the OTC hearing aid market created by the FDA in 2022.

By Nick Paul Taylor • April 3, 2025

Hospital-at-home companies DispatchHealth, Medically Home to merge

DispatchHealth CEO Jennifer Webster will lead the combined company once the deal closes, which is expected in mid-2025.

By Emily Olsen • March 21, 2025

Labcorp to buy Opko unit’s cancer test assets for up to $225M

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth testing areas.

By Susan Kelly • March 12, 2025

FTC challenges $627M private equity takeover of Surmodics

The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate significant head-to-head competition.”

By Nick Paul Taylor • March 7, 2025

Trump administration policies could create headwinds across healthcare: Fitch

The credit ratings agency is most concerned about Medicaid cuts and how government layoffs will affect device approvals.

By Susanna Vogel • March 5, 2025

Boston Scientific to buy Sonivie for up to $540M

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its Sonivie acquisition.

By Ricky Zipp • March 3, 2025

Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

By Susan Kelly • Feb. 27, 2025

Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

By Susan Kelly • Feb. 25, 2025

Quest to buy Fresenius Medical Care kidney testing assets

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests and other end-stage kidney disease services for Fresenius Medical Care.

By Nick Paul Taylor • Feb. 25, 2025

FTC retains stricter merger guidelines under Trump

FTC Chair Andrew Ferguson sent a memo to agency staff on Tuesday clarifying that the Biden-era guidelines will remain in place — for now.

By Rebecca Pifer • Feb. 20, 2025

Medtronic buys Nanovis’ nano technology for use in spine implants

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

By Nick Paul Taylor • Feb. 13, 2025

M&A and a separation take center stage in latest earnings season

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 billion buy of Paragon 28.

By Susan Kelly • Feb. 10, 2025

Globus to buy Nevro for $250M

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale and orthopedic relationships.

By Elise Reuter • Feb. 6, 2025

Zimmer touts ASC opportunity with Paragon 28 purchase

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace hips and knees.

By Elise Reuter • Feb. 6, 2025

Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty

Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.

By Ricky Zipp • Jan. 31, 2025

Zimmer to buy Paragon 28 for $1.1B

Needham analysts, who were surprised by the bargain for Paragon 28, said Zimmer may not be done spending.

By Ricky Zipp • Jan. 29, 2025

Stryker to sell spinal implants business

The company named a new CFO and shared an update on its planned Inari Medical acquisition.

By Elise Reuter • Jan. 29, 2025

Philips to sell emergency care business

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, for an undisclosed amount.

By Elise Reuter • Jan. 28, 2025

Intuitive inks deals to sell robots in Italy, Spain and Portugal

Intuitive is buying businesses that distribute its da Vinci and Ion surgical robots to establish a direct presence in Italy, Spain, Portugal, Malta and San Marino.

By Nick Paul Taylor • Jan. 23, 2025

Medtronic inks distribution deal with Contego with option to buy firm

Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and thrombectomy devices.

By Ricky Zipp • Jan. 13, 2025

5 medtech trends to watch in 2025

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

By Ricky Zipp • Jan. 9, 2025

Boston Scientific to buy remaining Bolt Medical stake for up to $664M

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.

By Susan Kelly • Jan. 8, 2025

Stryker to buy Inari Medical for nearly $5B

Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari Medical.

By Ricky Zipp • Jan. 6, 2025

Top 10 medtech deals of 2024

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

By Nick Paul Taylor • Jan. 2, 2025